Literature DB >> 21251225

Use and wear of anti-embolism stockings: a clinical audit of surgical patients.

Julie A Miller1.   

Abstract

The objective of this study was to determine if anti-embolism stockings are fitted and worn according to evidence-based guidelines in surgical patients. The methodology is that an observational study was undertaken during January and February, 2010. An audit tool was constructed for the recording of information on a variety of parameters relating to the correct fitting and wearing of anti-embolism stockings. The results show that eighty surgical patients were audited with a mean age of 66 years. Of these, 72.5% were ambulatory; 38.75% of patients had incorrect presentation of their stockings; 29% were fitted with the incorrect size for limb measurement and 70% of patients reported not receiving any information regarding the reason for anti-embolism stocking use. Written information was not received by 100% of participants. For 82.5% of participants deep vein thrombosis (DVT) risk was not recorded. The garment size fitted (and/or limb measurement) was not recorded for 100% of patients. Daily routine skin inspection was noted for 29%. The findings of this study showed that anti-embolism stockings were not fitted and worn according to evidence-based guidelines. The author recommends a new recording tool be developed to ensure consistency of assessment and documentation regarding risk assessment, contraindications identification, and education and monitoring of patients wearing anti-embolism stockings.
© 2011 The Author. © 2011 Blackwell Publishing Ltd and Medicalhelplines.com Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21251225      PMCID: PMC7950736          DOI: 10.1111/j.1742-481X.2010.00751.x

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  23 in total

Review 1.  Elastic compression stockings for prevention of deep vein thrombosis.

Authors:  S V Amaragiri; T A Lees
Journal:  Cochrane Database Syst Rev       Date:  2000

2.  Deep vein thrombosis--aetiology and prevention.

Authors:  S Geraghty; J Russell; S Gilbourne; J Young
Journal:  Nurs Times       Date:  2001 Apr 26-May 2

3.  Prevention of venous thromboembolism. International Consensus Statement. Guidelines compiled in accordance with the scientific evidence.

Authors:  A N Nicolaides; H K Breddin; J Fareed; S Goldhaber; S Haas; R Hull; E Kalodiki; K Myers; M Samama; A Sasahara
Journal:  Int Angiol       Date:  2001-03       Impact factor: 2.789

Review 4.  Deep vein thrombosis prophylaxis: the effectiveness and implications of using below-knee or thigh-length graduated compression stockings.

Authors:  Belinda Byrne
Journal:  J Vasc Nurs       Date:  2002-06

5.  A new anti-embolism stocking. Use of below-knee products and compliance.

Authors:  Claire Parnaby
Journal:  Br J Perioper Nurs       Date:  2004-07

6.  Best practice guidelines for Australia and New Zealand on the prevention of venous thromboembolism: issues and implications for nurses.

Authors:  Jessica Schluter; Hayden Scotter; Wendy Chaboyer
Journal:  Contemp Nurse       Date:  2008-05       Impact factor: 1.787

7.  Graduated compression stockings in hospitalized postoperative patients: correctness of usage and size.

Authors:  Elizabeth H Winslow; Debra L Brosz
Journal:  Am J Nurs       Date:  2008-09       Impact factor: 2.220

Review 8.  Prevention of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence).

Authors: 
Journal:  Int Angiol       Date:  1997-03       Impact factor: 2.789

9.  Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients.

Authors:  D Cook; J Attia; B Weaver; E McDonald; M Meade; M Crowther
Journal:  J Crit Care       Date:  2000-12       Impact factor: 3.425

10.  Should knee-length replace thigh-length graduated compression stockings in the prevention of deep-vein thrombosis?

Authors:  M F Hameed; D J Browse; E J Immelman; P A Goldberg
Journal:  S Afr J Surg       Date:  2002-02       Impact factor: 0.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.